EGR1 Regulation of Vasculogenic Mimicry in the MDA-MB-231 Triple-Negative Breast Cancer Cell Line through the Upregulation of KLF4 Expression

被引:3
|
作者
Jung, Euitaek [1 ]
Lee, Young Han [1 ,2 ]
Ou, Sukjin [1 ]
Kim, Tae Yoon [1 ]
Shin, Soon Young [1 ,2 ]
机构
[1] Konkuk Univ, Dept Biol Sci, Sanghuh Coll Life Sci s, Seoul 05029, South Korea
[2] Konkuk Univ, Canc & Metab Inst, Seoul 05029, South Korea
关键词
Early Growth Response 1; Kruppel-like factor 4; MDA-MB-231; cells; mitogen-activated protein kinase pathway; vasculogenic mimicry; EMT;
D O I
10.3390/ijms241814375
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vasculogenic mimicry (VM) is an intriguing phenomenon observed in tumor masses, in which cancer cells organize themselves into capillary-like channels that closely resemble the structure and function of blood vessels. Although VM is believed to contribute to alternative tumor vascularization, the detailed regulatory mechanisms controlling these cellular processes remain poorly understood. Our study aimed to investigate the role of Early Growth Response 1 (EGR1) in regulating VM in aggressive cancer cells, specifically MDA-MB-231 triple-negative breast cancer cells. Our study revealed that EGR1 promotes the formation of capillary-like tubes by MDA-MB-231 cells in a 3-dimensional Matrigel matrix. EGR1 was observed to upregulate Kruppel-like factor 4 (KLF4) expression, which regulates the formation of the capillary-like tube structure. Additionally, our findings highlight the involvement of the ERK1/2 and p38 mitogen-activated protein kinase pathways in mediating the expression of EGR1 and KLF4, underscoring their crucial role in VM in MDA-MB-231 cells. Understanding these regulatory mechanisms will provide valuable insights into potential therapeutic targets for preventing VM during the treatment of triple-negative breast cancer.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] ER81-shRNA Inhibits Growth of Triple-negative Human Breast Cancer Cell Line MDA-MB-231 In Vivo and in Vitro
    Chen, Yue
    Zou, Hong
    Yang, Li-Ying
    Li, Yuan
    Wang, Li
    Hao, Yan
    Yang, Ju-Lun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (05) : 2385 - 2392
  • [32] New insights into the cytotoxic effects of Thymus vulgaris essential oil on the human triple-negative breast cancer cell line MDA-MB-231
    Benedetti, Serena
    Nasoni, Maria Gemma
    Luchetti, Francesca
    Palma, Francesco
    TOXICOLOGY IN VITRO, 2023, 93
  • [33] In the triple-negative breast cancer MDA-MB-231 cell line, sulforaphane enhances the intracellular accumulation and anticancer action of doxorubicin encapsulated in liposomes
    Mielczarek, Lidia
    Krug, Pamela
    Mazur, Maciej
    Milczarek, Malgorzata
    Chilmonczyk, Zdzislaw
    Wiktorska, Katarzyna
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 558 : 311 - 318
  • [34] In Vitro and In Vivo Relevant Antineoplastic Activity of Platinum(II) Complexes toward Triple-Negative MDA-MB-231 Breast Cancer Cell Line
    Figueiredo Maciel, Leide Laura
    Silva, Marina Barreto
    Moreira, Rafaela Oliveira
    Cardoso, Ana Paula
    Fernandes, Christiane
    Horn Jr, Adolfo
    de Aquino Almeida, Joao Carlos
    Kanashiro, Milton Masahiko
    PHARMACEUTICS, 2022, 14 (10)
  • [35] Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231
    Liang, Weili
    Song, Shasha
    Xu, Yintao
    Li, Huiying
    Liu, Huantao
    MOLECULAR MEDICINE REPORTS, 2018, 17 (05) : 6711 - 6716
  • [36] SCD1 activity promotes cell migration via a PLD-mTOR pathway in the MDA-MB-231 triple-negative breast cancer cell line
    Marine Lingrand
    Simon Lalonde
    Antoine Jutras-Carignan
    Karl-F. Bergeron
    Eric Rassart
    Catherine Mounier
    Breast Cancer, 2020, 27 : 594 - 606
  • [37] Enhanced Apoptotic Effects in MDA-MB-231 Triple-Negative Breast Cancer Cells Through a Synergistic Action of Luteolin and Paclitaxel
    Tamanna, Shabnam
    Perumal, Elumalai
    Rajanathadurai, Jeevitha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [38] SCD1 activity promotes cell migration via a PLD-mTOR pathway in the MDA-MB-231 triple-negative breast cancer cell line
    Lingrand, Marine
    Lalonde, Simon
    Jutras-Carignan, Antoine
    Bergeron, Karl-F.
    Rassart, Eric
    Mounier, Catherine
    BREAST CANCER, 2020, 27 (04) : 594 - 606
  • [39] High Thermosensitivity of MDA-MB-231 Cells as a Prerequisite for Thermoradiosensitization of Triple-Negative Breast Cancer in Clinical Practice
    Yakimova, A. O.
    Kabakov, A. E.
    BIOLOGY BULLETIN, 2023, 50 (12) : 3293 - 3300
  • [40] Isoform Selectivity of HDAC Inhibitors Has a Significant Effect on PD-L1 Expression in the Triple-negative Cancer Cell Line MDA-MB-231
    Nishino, Hinata
    Hirata, Yoshiyuki
    Nagaoka, Yasuo
    Uesato, Shinichi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2022, 142 (04): : 431 - 437